SUSTAIN 340B Act and Legislative Developments in Healthcare
Explore the SUSTAIN 340B Act and recent healthcare legislative activities addressing Medicaid costs and fraud prevention efforts.
Proposed Rule for 2027 Physician Fee Schedule and 340B Program Changes
CMS proposes significant changes to the 340B program and Physician Fee Schedule, aiming for improved compliance and drug pricing strategies. Stakeholders can provide feedback.
CMS Proposes Major Changes to Medicare Part B Under 340B Program
CMS proposes adjustments to Medicare Part B payments for 340B-acquired outpatient drugs, impacting hospital reimbursement and healthcare finance significantly.
Phil Perry Retires: Impact on 340B Program Litigation and Regulation
Phil Perry's retirement signals notable changes in 340B litigation as CMS proposes a new rule impacting drug payments; public comment open through August 2026.
New Medicare Regulation Aims to Cut Drug Prices for Hospitals
The new Medicare regulation aims to reduce drug costs for hospitals, predicting $1.1 billion in savings for beneficiaries. Learn more about this significant change.
Proposed Medicare Outpatient Payment Changes: 2027 Adjustments
Discover proposed Medicare payment adjustments for 2027, impacting hospital funding and healthcare quality. Stakeholders urged to comment by August 31.
ASCO Updates 340B Drug Pricing Program Policy: Enhancing Oncology Care
Discover ASCO's updated 340B Drug Pricing Program policy aimed at enhancing access to oncology care for underserved populations.
340B Drug Pricing Program Expansion Impact on Illinois Employers
Explore how the proposed expansion of the 340B Drug Pricing Program could increase costs for Illinois employers and state health insurance plans.
Scrutiny on Hospitals Involving the 340B Drug Discount Program
Explore the impact of the 340B drug discount program on hospitals and insurance reimbursements, raising concerns about healthcare costs and regulatory compliance.
Florida Hospital Leaders Advocate for Healthcare Policy Changes
Florida hospital executives advocate for vital policy changes to improve healthcare access and affordability. Discover key insights from their D.C. meetings.